Catalytic Wealth Ria, LLC Takeda Pharmaceutical CO LTD Transaction History
Catalytic Wealth Ria, LLC
- $500 Billion
- Q1 2024
A detailed history of Catalytic Wealth Ria, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 20,862 shares of TAK stock, worth $287,269. This represents 0.06% of its overall portfolio holdings.
Number of Shares
20,862
Previous 16,354
27.57%
Holding current value
$287,269
Previous $233 Million
24.17%
% of portfolio
0.06%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
337Shares Held
76.1MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$181 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X012.1MShares$166 Million2.47% of portfolio
-
Morgan Stanley New York, NY5MShares$68.8 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.21MShares$58 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.12MShares$42.9 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...